Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Akari Murata"'
Publikováno v:
American journal of respiratory and critical care medicine. 205(8)
Autor:
Noriyuki Ohkura, Yuko Waseda, Yukari Ichikawa, Kazuo Kasahara, Akari Murata, Masahide Yasui, Satoshi Watanabe, Kazumasa Kase, Hazuki Takato, Keigo Saeki
Background: The clinical course of patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD) is highly variable. The Krebs von den Lungen-6 (KL-6) glycoprotein is a promising biomarker for reflectingepithelial injury. However, s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f5b0cd668e8be922e1388a7908aee75
https://doi.org/10.21203/rs.3.rs-861378/v1
https://doi.org/10.21203/rs.3.rs-861378/v1
Autor:
Yuko Waseda, Hazuki Takato, Miki Abo, Takashi Sone, Masahide Yasui, Kazuo Kasahara, Keigo Saeki, Kazumasa Kase, Akari Murata, Yukari Ichikawa, Johsuke Hara, Ohkura Noriyuki, Hideharu Kimura, Satoshi Watanabe
Publikováno v:
J Thorac Dis
Background The utility of bronchoalveolar lavage (BAL) in the evaluation of systemic sclerosis-associated interstitial lung disease (SSc-ILD) remains controversial. Fractional analysis of BAL (FBAL) is a technique that can analyze small airways and a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7990fb01e5d0aa1a2dabbdb9643717d7
https://europepmc.org/articles/PMC8339759/
https://europepmc.org/articles/PMC8339759/
Autor:
Noriyuki Ohkura, Kenta Yamamura, Kazuo Kasahara, Takashi Sone, Akari Murata, Miki Abo, Tomoyuki Araya, Hideharu Kimura, Johsuke Hara
Publikováno v:
Transl Lung Cancer Res
Awareness of the immune-related adverse event of programmed cell death protein-1 (PD-1) inhibitor-induced pneumonitis is important. Herein, we report the clinical course of 3 patients suspected to have PD-1 inhibitor-induced pneumonitis after cessati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03867ed160805d2d9ba39c996813e963
https://europepmc.org/articles/PMC8044496/
https://europepmc.org/articles/PMC8044496/
Autor:
Satoshi Watanabe, Yuko Waseda, Keigo Saeki, Kazuo Kasahara, Masahide Yasui, Akari Murata, Kazumasa Kase, Hazuki Takato, Noriyuki Ohkura, Yukari Ichikawa
Publikováno v:
Respiratory Medicine. 191:106689
Background The clinical course of patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD) is highly variable. The Krebs von den Lungen-6 (KL-6) glycoprotein is a promising biomarker for reflecting epithelial injury. However, s
Autor:
Kengo Furuichi, Kazuo Kasahara, Kazunori Yamada, Yuko Waseda, Masahide Yasui, Mitsuhiro Kawano, Satoshi Watanabe, Hazuki Takato, Yukari Ichikawa, Keigo Saeki, Hideharu Kimura, Takashi Wada, Akari Murata, Yasuhito Hamaguchi, Takashi Matsushita
Publikováno v:
Journal of Thoracic Disease. 10:799-807
Backgrounds: Lung cancer (LC) adversely impacts survival in patients with idiopathic pulmonary fibrosis. However, little is known about LC in patients with connective tissue disease-associated interstitial lung disease (CTD-ILD). The aim of this stud
Autor:
Hiroyuki Honda, Saki Ohsumi, Yohei Okada, Takumi Hisada, Stacy Hadiwidjaja, Ryuji Kato, Kazunori Shimizu, Takunori Nagashima, Akari Murata
Publikováno v:
Advanced Biosystems. 4:2000121
In the development process for drugs used to treat skeletal muscle, cell-based contractile force assays have been considered as a useful in vitro test. Immortalized human myogenic cells are promising as cell sources for reproducible and well-characte
Publikováno v:
BMJ case reports. 2018
We report two cases of pleurisy caused by non-tuberculous mycobacteria followed by pneumothorax. The onset of pleurisy was accompanied by acute fever. Cultured samples of the pleural effusions from the two patients, an 80-year-old man and an 87-year-
Autor:
Kazuo Kasahara, Hayato Koba, Johsuke Hara, Akari Murata, Yuichi Tambo, Miki Abo, Hideharu Kimura, Takashi Sone
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 108
We report the case of a 62-year-old man treated with nivolumab as fourth-line therapy for stage IV squamous cell carcinoma of the lung. Because of the onset of nivolumab-induced pneumonitis after 2 doses, nivolumab was discontinued. After discontinua
Autor:
Kenta Yamamura, Yuka Ikawa, Kazuo Kasahara, Hiroki Matsuoka, Akari Murata, Kota Tanimura, Keigo Saeki, Satoshi Watanabe, Yuichi Tambo
Publikováno v:
The Journal of Dermatology. 46:e118-e119